Ruslan Rafikov, PhD
Professor of Medicine
- Phone
- (317) 278-0432
- Address
-
R3 C400
PULM
IN
Indianapolis, IN - PubMed:
-
Bio
Dr. Ruslan Rafikov is a Professor of Medicine at Indiana University's Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine, where he leads groundbreaking research in pulmonary hypertension, acute lung injury, and hemolytic conditions. With over 70 peer-reviewed publications in high-impact journals, he has significantly contributed to understanding the mechanisms of pulmonary vascular disorders, particularly through his expertise in protein engineering, metabolomics, and single-cell transcriptomics.
As a principal investigator currently funded by two R01 grants exceeding $6 million, Dr. Rafikov has demonstrated exceptional research productivity while fostering the next generation of scientists, with his team members securing numerous fellowships and awards. His innovative work has resulted in more than 12 patents related to small molecules, peptides, biologics, and diagnostics, leading to the co-founding of Metfora LLC, a diagnostic startup utilizing blood metabolomics and AI for chronic disease detection.
| Year | Degree | Institution |
|---|---|---|
| 2005 | PhD | Moscow Institute of Physics and Technology |
| 1997 | MS | Moscow State University |
Pulmonary Hypertension and Acute Lung Injury: Investigating disease mechanisms and therapeutic approaches Metabolic Reprogramming: Understanding cellular metabolism changes in lung diseases using metabolomics and machine learning Protein Engineering: Developing novel therapeutic proteins and studying post-translational modifications Single Cell Biology: Analyzing lung vascular cell populations and their roles in disease progression Mitochondrial Biology: Examining the role of mitochondrial dysfunction in pulmonary vascular disorders Translational Research: Leading diagnostic innovations through metabolomics and AI-based approaches.